Infertility. Female infertility
Conditions
Interventions
Intervention 1: Intralipid Group: Intravenous infusion of 100 milliliters of 20 percent Intralipid solution (a sterile fat emulsion containing soybean oil and egg yolk phospholipids) diluted in 500 mi
Sponsors
Vice-Chancellery for Research and Technology, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women diagnosed with adenomyosis candidates for IVF Informed consent
Exclusion criteria
Exclusion criteria: Hypersensitivity to Intralipid Components
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Live Birth Rate. Timepoint: At the end of the pregnancy period. Method of measurement: Birth of a living fetus showing signs of life after the completion of the pregnancy period.;Clinical pregnancy rate. Timepoint: six weeks after the embryo transfer procedure. Method of measurement: Visualization of a gestational sac and fetal heartbeat via ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Blood test to measure the level of beta human chorionic gonadotropin hormone.;Abortion rate. Timepoint: twentieth week of gestation. Method of measurement: Obtaining a clinical history from the patient and performing transvaginal or abdominal ultrasound to confirm pregnancy loss.;Implantation success rate. Timepoint: six weeks after embryo transfer. Method of measurement: Use of transvaginal ultrasound to count the number of formed gestational sacs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Heidar
Shahid Beheshti University of Medical Sciences
Outcome results
None listed